BCAN's Patient Handbook - Bladder Cancer Basics for the Newly Diagnosed



Donate Now to Support the Bladder Cancer Advocacy Network



Join The Online Bladder Cancer Support Community



The Bladder Cancer Advocacy Network (BCAN) is proud to announce that we have been designated a Marine Corps Marathon (MCM) Charity Partner! BCAN has been allocated 25 guaranteed entries for the 38th Annual Marine Corps Marathon to be held on October 27, 2013; an event that sold out in 2 hours and 41 minutes in 2012.
  • We are looking at building “Team BCAN” to not only run in the event and raise awareness for bladder cancer but to raise needed funds for fostering research and patient education. According to the Marine Corps Marathon, there is not a required qualifying time to participate in the event, but all runners should maintain at least a 14 minute mile pace. In order to become a member of “Team BCAN” and officially have a slot in this year’s race, you must be registered through BCAN.
  • No federal or Marine Corps endorsement is implied.
  • If you are interested in becoming a member of BCAN’s team or have any questions, please contact Larry Rzepka, BCAN’s Executive Director, at lrzepka@bcan.org.
  • sam-chang.bmp

    Sam S. Chang, M.D.
    Associate Professor Department of Urologic Surgery
    Vanderbilt University School of Medicine

    Dr. Chang received his undergraduate degree from Princeton University and his medical degree from Vanderbilt University School of Medicine. He completed an internship in general surgery and residencies in general surgery and urologic surgery at Vanderbilt University Medical Center, as well as a fellowship in urologic oncology at Memorial Sloan-Kettering Cancer Center in New York City where he was named Chief Fellow.

    In 2005, Dr. Chang was the first ever recipient of the Distinguished Service Award of the Society of Urologic Oncology, and in 2007 was named a Best Reviewer by The Journal of Urology.   Dr. Chang is an investigator for the Eastern Cooperative Oncology Group and the American College of Surgeons Oncology Group, and a member of the AUA Exam Committee, American Association for Cancer Research, the American Urological Association, the Society of Urologic Oncology, and the American Association of Clinical Urologists, Inc.

    He is the Chairman of the AJCC GU Staging Task Force responsible for prognostic staging assignments for all urologic cancers.  He was the Vice Chairman of the American Urologic Association Guidelines Panel on Non Invasive Bladder Cancer that were recently published in 2007.  He continues to serve on the Executive Board of the Society of Urologic Oncology.

    Dr. Chang has been involved with numerous clinical trials as either a principal investigator or a subinvestigator that involve bladder cancer at different stages. He has authored more than 150 publications involving different urologic cancers.
    Click here for more information.